Blood test breakthrough could better predict leukemia survival
NCT ID NCT04641910
First seen Apr 19, 2026 · Last updated May 21, 2026 · Updated 5 times
Summary
This study aims to confirm that measuring two substances in the blood (FLT3L and IL-6) during the first round of chemotherapy can help predict how well patients with acute myeloid leukemia (AML) will do. Researchers will track 201 newly diagnosed AML patients across 25 French hospitals. The goal is to create a more accurate risk classification to guide treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AP-HP Cochin Hospital
Paris, 75014, France
-
Angers University Hospital
Angers, Maine-et-Loire, 49000, France
-
Basque coast hospital center
Bayonne, Pyrénées-Atlantiques, 64102, France
-
Besançon University Hospital
Besançon, Doubs, 25000, France
-
Bordeaux University Hospital
Bordeaux, Gironde, 33076, France
-
Brest University Hospital
Brest, Finistère, 29200, France
-
Béziers Hospital Center
Béziers, Hérault, 34500, France
-
Clermont-Ferrand University Hospital
Clermont-Ferrand, Puy-de-Dôme, 63000, France
-
Grenoble University Hospital
Grenoble, Isère, 38000, France
-
Lyon University Hospital
Lyon, Rhône, 69000, France
-
Mercy Regional Hospital
Metz, Moselle, 57000, France
-
Montpellier University Hospital
Montpellier, Hérault, 34295, France
-
Mulhouse Hospital Center
Mulhouse, Haut-Rhin, 68100, France
-
Nancy University Hospital
Nancy, Meurthe-et-Moselle, 54000, France
-
Nantes University Hospital
Nantes, Loire-Atlantique, 44093, France
-
Nîmes University Hospital
Nîmes, Gard, 30000, France
-
Paoli-Calmette Institute
Marseille, Bouches-du-Rhône, 13000, France
-
Poitiers University Hospital
Poitiers, 86000, France
-
Reims University Hospital
Reims, Marne, 51100, France
-
Rennes University Hospital
Rennes, Ille-et-Vilaine, 35033, France
-
Saint-Etienne University Hospital
Saint-Étienne-de-Montluc, Pays de la Loire Region, 42000, France
-
Saint-Jean Hospital Center
Perpignan, Pyrénées-Orientales, 66000, France
-
Strasbourg University Hospital
Strasbourg, Bas-Rhin, 67200, France
-
Toulouse University Cancer Institute
Toulouse, Haute-Garonne, 31000, France
-
Tours University Hospital
Tours, Indre-et-Loire, 37000, France
Conditions
Explore the condition pages connected to this study.